A detailed history of Credit Agricole S A transactions in Abbott Laboratories stock. As of the latest transaction made, Credit Agricole S A holds 1,400,086 shares of ABT stock, worth $162 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares
1,400,086
Previous 846,760 65.35%
Holding current value
$162 Million
Previous $88 Million 81.42%
% of portfolio
0.7%
Previous 0.48%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.07 - $118.13 $55.4 Million - $65.4 Million
553,326 Added 65.35%
1,400,086 $160 Million
Q2 2024

Aug 13, 2024

BUY
$100.73 - $112.44 $68.3 Million - $76.3 Million
678,318 Added 402.7%
846,760 $88 Million
Q1 2024

May 14, 2024

BUY
$109.52 - $120.96 $5.6 Million - $6.18 Million
51,089 Added 43.53%
168,442 $19.1 Million
Q4 2023

Feb 13, 2024

BUY
$90.19 - $110.4 $4.85 Million - $5.94 Million
53,821 Added 84.71%
117,353 $12.9 Million
Q3 2023

Nov 14, 2023

BUY
$95.53 - $114.62 $2.12 Million - $2.55 Million
22,226 Added 53.81%
63,532 $6.15 Million
Q2 2023

Jul 31, 2023

SELL
$100.78 - $112.29 $461,471 - $514,175
-4,579 Reduced 9.98%
41,306 $4.5 Million
Q1 2023

May 12, 2023

BUY
$96.86 - $114.01 $1.5 Million - $1.77 Million
15,512 Added 51.07%
45,885 $4.65 Million
Q4 2022

Feb 13, 2023

SELL
$95.06 - $111.52 $75,762 - $88,881
-797 Reduced 2.56%
30,373 $3.34 Million
Q3 2022

Nov 10, 2022

BUY
$96.76 - $112.03 $27,479 - $31,816
284 Added 0.92%
31,170 $3.02 Million
Q2 2022

Aug 08, 2022

BUY
$102.07 - $123.37 $262,319 - $317,060
2,570 Added 9.08%
30,886 $3.36 Million
Q1 2022

May 16, 2022

BUY
$114.02 - $139.04 $992,772 - $1.21 Million
8,707 Added 44.4%
28,316 $3.35 Million
Q4 2021

Feb 14, 2022

SELL
$115.53 - $141.46 $885,884 - $1.08 Million
-7,668 Reduced 28.11%
19,609 $2.76 Million
Q3 2021

Nov 15, 2021

BUY
$116.66 - $129.06 $1.25 Million - $1.39 Million
10,737 Added 64.92%
27,277 $3.22 Million
Q2 2021

Aug 10, 2021

SELL
$105.79 - $124.53 $4.38 Million - $5.16 Million
-41,447 Reduced 71.48%
16,540 $1.92 Million
Q1 2021

May 17, 2021

BUY
$108.84 - $128.23 $3.98 Million - $4.69 Million
36,564 Added 170.68%
57,987 $6.95 Million
Q4 2020

Feb 12, 2021

SELL
$105.0 - $114.42 $3.63 Million - $3.95 Million
-34,537 Reduced 61.72%
21,423 $2.35 Million
Q3 2020

Nov 13, 2020

BUY
$91.64 - $111.29 $182,363 - $221,467
1,990 Added 3.69%
55,960 $6.09 Million
Q2 2020

Aug 13, 2020

BUY
$76.57 - $98.0 $423,202 - $541,646
5,527 Added 11.41%
53,970 $4.93 Million
Q1 2020

May 14, 2020

SELL
$62.82 - $91.86 $655,024 - $957,824
-10,427 Reduced 17.71%
48,443 $3.82 Million
Q4 2019

Feb 12, 2020

SELL
$78.51 - $87.4 $5.43 Million - $6.04 Million
-69,158 Reduced 54.02%
58,870 $5.11 Million
Q3 2019

Nov 08, 2019

SELL
$81.84 - $88.74 $642,935 - $697,141
-7,856 Reduced 5.78%
128,028 $10.7 Million
Q2 2019

Aug 14, 2019

SELL
$72.88 - $85.0 $74,629 - $87,040
-1,024 Reduced 0.75%
135,884 $11.4 Million
Q1 2019

May 14, 2019

SELL
$66.22 - $80.06 $150,120 - $181,496
-2,267 Reduced 1.63%
136,908 $10.9 Million
Q4 2018

Feb 13, 2019

BUY
$65.56 - $74.27 $1.31 Million - $1.48 Million
19,930 Added 16.71%
139,175 $10.1 Million
Q3 2018

Nov 13, 2018

BUY
$60.81 - $73.36 $1.82 Million - $2.2 Million
29,949 Added 33.54%
119,245 $8.75 Million
Q2 2018

Aug 10, 2018

SELL
$57.57 - $63.54 $625,267 - $690,107
-10,861 Reduced 10.84%
89,296 $5.45 Million
Q1 2018

May 14, 2018

SELL
$56.27 - $63.62 $575,360 - $650,514
-10,225 Reduced 9.26%
100,157 $6 Million
Q4 2017

Feb 13, 2018

SELL
$53.68 - $57.47 $34.7 Million - $37.2 Million
-647,320 Reduced 85.43%
110,382 $6.3 Million
Q3 2017

Nov 14, 2017

BUY
$48.06 - $53.64 $4.94 Million - $5.51 Million
102,754 Added 15.69%
757,702 $40.4 Million
Q2 2017

Aug 14, 2017

BUY
N/A
654,948
654,948 $31.8 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Credit Agricole S A Portfolio

Follow Credit Agricole S A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

News

Stay updated on Credit Agricole S A with notifications on news.